Scientists at the Indian Institute of Genomics and Integrative Biology have developed a new test for detecting COVID-19, which is able to recognize its genomic sequence.

The Ministry of Science and Technology of the country clarified that the development, dubbed Tata CRISPR, has already been approved by regulators from the General Controller of Medicines of India for commercial launch..

It is noted that Tata CRISPR is the world's first diagnostic test using a specially adapted Cas9 protein, in addition, it uses the latest genome editing technology to diagnose CRISPR diseases.

According to the Indian agency, the sensitivity of the new test is 96 percent and the specificity is 98 percent.. The new system provides the level of accuracy of traditional PCR tests, while saving time and money, the report says..